The Interaction between GABA-Ergic Drugs and Dopaminergic Stimulants
In the human brain there is evidence for a functional dysbalance between γ-aminobutyric acid (GABA) and dopamine in Parkinson’s disease and Huntington’s chorea (McGeer and McGeer, 1976). In both diseases there are a pronounced decrease in GABA and its synthesizing enzyme glutamic acid decarboxylase (GAD) in the basal ganglia system. Dopamine is in addition decreased in parkinsonism. A useful new therapeutic strategy for these diseases might be a supplementary treatment with drugs which increase GABA receptor activity. Obviously there is a need for methods measuring the specific pharmacological effects of GABA-ergic drugs in vivo. This lack has consequently limited conclusions based on clinical trials with apparently unspecific drugs like baclofen (Naik et al, 1976). As a model compound we used muscimol which until now has shown to be the most potent and selective GABA-agonist able to penetrate the bloodbrain barrier (Naik et al, 1976; Scheel-Krüger et al, 1977 a). We investigated the behavioural interactions of different putative GABA-ergic drugs with morphine and different dopaminergic stimulants. As an animal model for dopaminergic activity we used the stereotyped behaviour and locomotor activity induced by methylphenidate, apomorphine and cocaine.
KeywordsDopamine Cage Morphine Cocaine Posite
Unable to display preview. Download preview PDF.
- Haefely, W., Kulcsar, A., Möhler, H., Pieri, L., Pole, P., and Schaffner, R., 1977, Possible involvement of GABA in the central actions of benzodiazepines, in “Mechanism of Action of Benzodiazepines” (E. Costa and P. Greengard, eds.), pp. 131–151, Raven Press, New York.Google Scholar
- Scheel-Krüger, J., Arnt, J., and Magelund, G., 1977 a, Behavioural stimulation induced “by muscimol and other GABA agonists injected into the substantia nigra, Neuroscience Letters 4: 351–356.Google Scholar
- Scheel-Krüger, J., Brasstrup, C., Nielsen, M., Golembiowska, K. and Mogilnicka, E., 1977, Cocaine: Discussion of the role of dopamine in the biochemical mechanism of action, in “Cocaine and other stimulants” (E.H. Ellinwood and M.M. Kilbey, eds.), pp. 373–407, Plenum Press, New York.CrossRefGoogle Scholar